Dr. Barry Slon

Qualifications

• MBChB
• FANZCA
• FFPMANZCA

Professional Memberships

• Australian Pain Society
• Neuromodulation Society of Australia and New Zealand

Positions

• Director, Melbourne Pain Group
• Additional Professional Activities and Contributions
• Honorary Adjunct Lecturer, Monash University (2010-2013)
• Contributor, Monash Anaesthesia Registrar Training Scheme (2007-2016)

Additional Professional Activities and Contributions

• Honorary Adjunct Lecturer, Monash University (2010-2013)
• Contributor, Monash Anaesthesia Registrar Training Scheme (2007-2016)

Publications

• Li Y, Jackson KA, Slon B, Hardy JR, Franco M, William L, Poon P, Coller JK, Hutchinson MR, Currow DC, Somogyi: AA 2015.
  “CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects”. British Journal of Clinical Pharmacology, Feb 2015.
• WL. Ng, TG. Short, KN. Gunn, GS. Fuge, B. Slon: 2014.
  “Accuracy and reliability of the i-STAT point-of-care device for the determination of haemoglobin concentration before and after major blood loss”. Anaesthesia and Intensive Care 42 (4).
• “Accuracy, precision and reliability of the i-STAT haemoglobin measurement device”. Free paper presentation, 2008 ANZCA ASM (Presentation by co-author).
• El-Seweisy O and Slon B: 2010. “Analgesic Effect of Subanaesthetic Intravenous Ketamine in Refractory Neuropathic Pain: A Case Report”. Pain Medicine, 11(6).